The FDA in July 2025 made publicly available over 200 complete response letters--an initiative that the investment community sees as "unanimously positive," analysts told BioSpace.
pharminent
April 23, 2026 (Last updated: April 23, 2026)
BioSpace
The FDA in July 2025 made publicly available over 200 complete response letters–an initiative that the investment community sees as “unanimously positive,” analysts told BioSpace.
